USANA Health Sciences Inc (USNA) company profile
Close on Nov 17, 2026Market cap $250.73MP/E –Yield –
About USANA Health Sciences
Medicinal Chemicals & Botanical Products, SIC 2833
USANA Health Sciences, Inc. develops and manufactures nutritional supplements, functional foods, and personal care products. The company organizes its operations into two reportable segments: Core nutritional and Hiya direct-to-consumer. Its offerings include targeted supplements, core vitamin and mineral supplements, meal replacement shakes, snack bars, skincare lines, and children's wellness items like chewable multivitamins and probiotics. Core nutritional products serve Brand Partners—who act as independent distributors and purchase for personal use—and Preferred Customers, who buy solely for personal consumption. Hiya serves retail consumers directly, primarily through a subscription model.
The company operates across twenty-five geographic markets worldwide within two main regions: Asia Pacific and Americas and Europe. Its business in China is conducted through BabyCare, which maintains manufacturing facilities in Beijing and Tianjin. USANA maintains corporate headquarters, alongside manufacturing and quality control facilities, in Salt Lake City, Utah.
Summary of the business section of USANA Health Sciences's latest annual report, written by StockData.
Company profile
Company
- Legal name
- USANA Health Sciences Inc
- Founded
- 1992
- Headquarters
- Salt Lake City, UT
- Address
- 3838 West Parkway Blvd. 84120-6336
- Phone
- (801) 954-7100
- Website
- www.usana.com
- Employees
- 1,570, Jan 3, 2026
- Industry
- Medicinal Chemicals & Botanical Products
- Incorporated in
- Utah
- Fiscal year ends
- January 3
- Auditor
- KPMG LLP, Salt Lake City, Utah
Stock & identifiers
- Ticker
- USNA
- Exchange
- NYSE
- Shares outstanding
- 18M, Aug 11, 2026
- Public float
- $328.00M, Jun 27, 2025
- Filer category
- Accelerated filer
- Stock splits
- 2-for-1, Nov 23, 2016; 2-for-1, Oct 31, 2003; 2-for-1, Aug 4, 1998
- SEC CIK
- 896264
- CUSIP
- 90328M107
- ISIN
- US90328M1071
- FIGI
- BBG000BX28M0
- Share class FIGI
- BBG001S79BP0
- LEI
- 549300YTURXE814MAH96
- EIN
- 87-0500306
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Peter Benedict | CHIEF INFORMATION OFFICER | 422 |
| Kathryn Michelle Armstrong | CHIEF SCIENTIFIC OFFICER | 3,989 |
| Brent Neidig | CHIEF COMMERCIAL OFFICER | 0 |
| Paul A. Jones | CHIEF PEOPLE OFFICER | 0 |
| G. Doug Iiekking | CHIEF FINANCIAL OFFICER | 708 |
| Joshua Foukas | CHIEF LEGAL OFFICER | 0 |
| Kevin Guest | CEO & EXEC. CHAIRMAN OF BOARD | 49,070 |
| Walter Noot | CHIEF OPERATING OFFICER | 9,256 |
| David Mulham Mulham | CHIEF SALES OFFICER | 8,387 |
| Jim Brown | CEO & PRESIDENT | 18,753 |
| J. Scott Nixon | Director | 13,077 |
| Peggie Pelosi | Director | 6,758 |
| John Turman Fleming | Director | 7,494 |
| Frederic J. Winssinger | Director | 11,365 |
| Xia Ding | Director | 9,306 |
| Gilbert A. Fuller | Director | 3,264 |
| Timothy E. Wood | Director | 13,061 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 | $4.34M | $2.39M | $1.58M | $25 | $49 |
| FY2024 | $3.36M | $2.07M | $1.36M | $46 | $94 |
| FY2023 Mr.Brown | $2.47M | $2.38M | $1.33M | $70 | $47 |
| FY2023 Mr.Guest | $3.91M | $3.84M | $1.33M | $70 | $47 |
| FY2022 | $3.75M | -$592.26K | $1.43M | $69 | $62 |
| FY2021 | $3.91M | $5.96M | $1.57M | $131 | $97 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Bonus | Stock awards | Incentive pay | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|---|
| Jim H. Brown Chief Executive Officer & President (former) | $821.23K | – | $3.15M | $339.17K | $32.21K | $4.34M | +29% |
| G. Douglas Hekking Chief Financial Officer | $568.53K | $175.00K | $855.68K | $83.01K | $16.40K | $1.70M | +18% |
| Walter Noot Chief Operating Officer | $564.90K | $196.08K | $850.24K | $82.48K | $25.60K | $1.72M | +20% |
| Joshua Foukas Chief Legal Officer & General Counsel | $500.57K | $175.00K | $753.40K | $73.08K | $12.25K | $1.51M | +19% |
| Brent Neidig Chief Commercial Officer | $513.52K | – | $772.88K | $77.03K | $12.25K | $1.38M | +6% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
Employees
Headcount reported in annual reports
“As of January 3, 2026, we had approximately 1,570 employees working in 22 countries worldwide, as measured by full-time equivalency.”
Corporate history
Events identified from SEC filings
See a number that looks wrong?